State of Wyoming’s Utah Medical Products UTMD Stock Holding History

State of Wyoming’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	4,803 +2,000	+71%	+$133K	0.03%	657
2026 Q1	$174K	Sell	2,803 -7	-0.2%	-$441	0.02%	1037
2025 Q4	$157K	Buy	2,810 +476	+20%	+$27.6K	0.02%	1114
2025 Q3	$147K	Buy	2,334 +23	+1%	+$1.36K	0.02%	1116
2025 Q2	$132K	Buy	+2,311	New	+$126K	0.02%	1163
2024 Q4	–	Sell	-2,308	Closed	-$154K	–	1873
2024 Q3	$154K	Buy	2,308 +466	+25%	+$31.6K	0.02%	881
2024 Q2	$123K	Buy	+1,842	New	+$125K	0.02%	887
2022 Q2	–	Sell	-211	Closed	-$19K	–	2148
2022 Q1	$19K	Buy	211 +29	+16%	+$2.67K	0.01%	1456
2021 Q4	$18K	Buy	182 +1	+0.6%	+$102	0.01%	1510
2021 Q3	$17K	Buy	181 +34	+23%	+$3K	0.01%	968
2021 Q2	$13K	Buy	+147	New	+$12.7K	0.01%	989

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State of Wyoming's UTMD Position: Q2 2026 in Review

State of Wyoming increased its Utah Medical Products (UTMD) stake by 71% in Q2 2026, buying an estimated $133K and bringing the position to 4,803 shares worth $331K. The position accounts for 0.03% of the portfolio, ranked #657.

State of Wyoming first reported a position in UTMD in Q2 2021 and has held it in 11 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

State of Wyoming held 4,803 shares of Utah Medical Products worth $331K as of Q2 2026.
State of Wyoming bought 2,000 Utah Medical Products shares in Q2 2026, an estimated $133K.
Utah Medical Products made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #657 holding.
State of Wyoming first reported a position in Utah Medical Products in Q2 2021 and has held it in 11 quarters since.
114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.